ArticleMaterials today. Bio2025
Ultrasound-responsive drug-carrying microbubbles combined with piezoelectric porous titanium scaffolds for the treatment of infected bone defects.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Piezo channels in physical field therapy: From mechanotransduction mechanisms to bioelectromagnetic modulation and biomedical applications.Mechanobiology in medicine · 2026Review
- Immunomodulatory Effects of Clinically Used Fat Emulsion to Promote Angiogenesis and Osteogenesis for Bone Repair.Materials (Basel, Switzerland) · 2026Article
- Ultrasound-responsive microbubbles in refractory infection niches: multi-front targeting of microenvironmental tolerance and local delivery of toxicity-limited antibiotics.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infected bone defects are a challenging issue in clinical orthopedics. Traditional scaffolds are prone to bacterial adhesion, colonization, and biofilm formation under infected conditions, making infection difficult to control. Additionally, severe infections can lead to tissue cell necrosis, hindering the bone repair process. In recent years, advancements in materials science and biomedical technology have driven the development of porous titanium alloy scaffolds that combine infection control with osteogenic functionality. By integrating antimicrobial properties with osteogenic potential, these scaffolds hold promise to overcome the limitations of traditional treatments and achieve early repair of infectious bone defects. Therefore, developing a porous titanium alloy scaffold that can effectively control infection and promote bone tissue regeneration under infected conditions is of significant importance for the clinical treatment of infectious bone defects. This study aims to explore the design and preparation of a dual-functional porous titanium alloy scaffold with antibacterial and bone repair capabilities, and to validate its application efficacy in infectious bone defects, with the goal of providing a more efficient and safer solution for clinical treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.